← All trials
NCT06692933
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 20, 2024
- Primary completion
- Aug 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- Nov 18, 2024
- Last posted
- Nov 18, 2024
- Enrollment
- 24
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Washington State UniversityLead sponsor
- Washington State UniversitySponsor investigator
- Office of Dietary Supplements (ODS)Collaborator
- National Center for Complementary and Integrative Health (NCCIH)Collaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.